Form 4: Arcellx Director Rami Elghandour Executes Stock Transactions and Grants Power of Attorney
SEC Form 4 Filing
Arcellx director Rami Elghandour acquired and disposed of company stock, including through the vesting of restricted stock units, and granted a power of attorney for SEC filings.
Summary
- Rami Elghandour, a director at Arcellx, Inc., engaged in multiple transactions involving the company's common stock.
- These transactions included the acquisition of 55,459 shares on January 2, 2025, and 53,097 shares on January 3, 2025, both at a price of $0, likely due to the vesting of restricted stock units.
- He also sold 14,857 shares on January 3, 2025, at an average price of $79.5481 and 13,776 shares on January 6, 2025, at an average price of $77.1668.
- These sales were to cover tax obligations related to the vesting of restricted stock units.
- Additionally, Elghandour was granted 223,964 restricted stock units on January 6, 2025.
- Elghandour also granted a power of attorney to several individuals to handle SEC filings on his behalf.
Sentiment
Score: 7
Explanation: The document reflects routine insider transactions and a standard power of attorney, which are neutral to slightly positive as they indicate continued engagement by a key executive. There is no indication of any negative sentiment.
Industry Context
This is a standard SEC Form 4 filing, which is common for company insiders who trade their company's stock. It provides transparency into the transactions of key personnel.
Comparison to Industry Standards
- The vesting schedule of the restricted stock units, with one-third vesting annually over three years or one-fourth vesting annually over four years, is a common practice in the biotechnology industry for employee equity compensation.
- The sale of shares to cover tax obligations upon vesting is also a standard practice for employees receiving equity compensation.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the sale of shares by a director, but this is a common occurrence and is not expected to have a significant impact.
- The vesting of restricted stock units is a positive for the executive as it is part of their compensation package.
Key Dates
| Date | Description |
|---|---|
| 2023-01-03 | RSU Grant Date for 53,097 shares that vest over three years. |
| 2024-01-02 | RSU Grant Date for 55,459 shares that vest over three years. |
| 2024-12-13 | Date of execution of the Power of Attorney. |
| 2025-01-02 | Acquisition of 55,459 shares and vesting of 55,459 restricted stock units. |
| 2025-01-03 | Acquisition of 53,097 shares, vesting of 53,097 restricted stock units and sale of 14,857 shares. |
| 2025-01-06 | Grant of 223,964 restricted stock units and sale of 13,776 shares. |
Keywords
Arcellx, Rami Elghandour, stock transactions, restricted stock units, SEC Form 4, power of attorney, insider trading, equity compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.